Abstract
Objective
To explore the risk factors for adverse pregnancy outcomes (APOs) in women with rheumatoid arthritis (RA) and the influence on their offspring health.
Methods
Pregnant women with RA (n = 67) who were hospitalized in the Department of Obstetrics, Peking University People’s Hospital between January 2007 and September 2021 were included in this study. Participants were evaluated at least once in each trimester and postpartum. Fetal outcomes and RA disease activity were extracted from medical records, and the offspring of enrolled patients were followed up. Associations between RA disease activity, medication use, and pregnancy outcomes were analyzed.
Results
The incidence of APOs in our cohort was 43.3%. Postpartum hemorrhage (20.9%) was the commonest complication, followed by premature delivery (11.9%). Previous miscarriages [odds ratio (OR): 1.869, 95% confidence interval (CI): 1.053–3.318, P = 0.033] and antinuclear antibody (ANA) positivity (OR:3.168, 95% CI: 1.068–9.768, P = 0.045) were risk factors for APOs. Compared to patients with APOs, the remission rate of disease activity during pregnancy was higher in patients without APOs (P = 0.027). There were no significant differences between patients with and without APOs with respect to daily and cumulative doses of prednisone (P > 0.05). The average age of the offspring was 4.9 years (range 0.3–14 years). Long-term follow-up showed no significant differences in offspring health between the two groups (P > 0.05).
Conclusion
Previous miscarriages and ANA positivity are independent risk factors for APOs in RA patients, while adverse pregnancy outcomes and low-dose prednisone have no effect on offspring health.
Key points • Previous miscarriages and ANA positivity are risk factors for APOs in RA patients. • Adverse pregnancy outcomes and low-dose prednisone during pregnancy have no effect on offspring health. |
Similar content being viewed by others
References
Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K (2012) Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 64(5):668–674. https://doi.org/10.1002/acr.21593
Eudy AM, McDaniel G, Clowse M (2018) Pregnancy in rheumatoid arthritis: a retrospective study. Clin Rheumatol 37:789–794. https://doi.org/10.1007/s10067-017-3939-4
Brouwer J, Fleurbaaij R, Hazes J et al (2017) Subfertility in women with rheumatoid arthritis and the outcome of fertility assessments. Arthritis Care Res (Hoboken) 69:1142–1149. https://doi.org/10.1002/acr.23124
Brouwer J, Hazes JM, Laven JS et al (2015) Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 74:1836–1841. https://doi.org/10.1136/annrheumdis-2014-205383
de Jong PH, Dolhain RJ (2017) Fertility, pregnancy, and lactation in rheumatoid arthritis. Rheum Dis Clin North Am 43:227–237. https://doi.org/10.1016/j.rdc.2016.12.004
Lin HC, Chen SF, Lin HC et al (2010) Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 69:715–717. https://doi.org/10.1136/ard.2008.105262
Smith C, Förger F, Bandoli G et al (2019) Factors associated with preterm delivery among women with rheumatoid arthritis and women with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 71:1019–1027. https://doi.org/10.1002/acr.23730
Harris N, Eudy A, Clowse M (2019) Patient-reported disease activity and adverse pregnancy outcomes in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 71:390–397. https://doi.org/10.1002/acr.23621
Giles I, Yee CS, Gordon C (2019) Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol 15:391–402. https://doi.org/10.1038/s41584-019-0240-8
de Man YA, Hazes JM, van der Heide H et al (2009) Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 60:3196–3206. https://doi.org/10.1002/art.24914
Bharti B, Lee SJ, Lindsay SP et al (2015) Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of teratology information specialists autoimmune diseases in pregnancy project. J Rheumatol 42:1376–1382. https://doi.org/10.3899/jrheum.140583
Al Rayes H, Abdulaziz S, Alotaibi AM et al (2021) Adverse impact of rheumatoid arthritis on pregnancy outcomes: a Saudi arabia prospective multicenter study. Open Access Rheumatol 13:167–175. https://doi.org/10.2147/OARRR.S315867
Sharma UR, Nediyedath Rathnakaran A, Raj B et al (2021) The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy. Inflammopharmacology 29:987–1000. https://doi.org/10.1007/s10787-021-00808-9
Louie GH, Ward MM (2010) Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983–2007. Ann Rheum Dis 69:868–871. https://doi.org/10.1136/ard.2009.112474
Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324. https://doi.org/10.1002/art.1780310302
Wallenius M, Skomsvoll JF, Irgens LM et al (2011) Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 63:1534–1542. https://doi.org/10.1002/art.30210
de Man YA, Dolhain RJ, van de Geijn FE et al (2008) Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 59:1241–1248. https://doi.org/10.1002/art.24003
Felson DT, Smolen JS, Wells G et al (2011) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70:404–413. https://doi.org/10.1136/ard.2011.149765
Langen ES, Chakravarty EF, Liaquat M et al (2014) High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 31:9–14. https://doi.org/10.1055/s-0033-1333666
Rom AL, Wu CS, Olsen J et al (2014) Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol 66:3265–3273. https://doi.org/10.1002/art.38874
Nørgaard M, Larsson H, Pedersen L et al (2010) Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 268:329–337. https://doi.org/10.1111/j.1365-2796.2010.02239.x
Ehrmann Feldman D, Vinet É, Bernatsky S et al (2016) Birth outcomes in women with a history of juvenile idiopathic arthritis. J Rheumatol 43:804–809. https://doi.org/10.3899/jrheum.150592
Kishore S, Mittal V, Majithia V (2019) Obstetric outcomes in women with rheumatoid arthritis: results from Nationwide Inpatient Sample Database 2003–2011. Semin Arthritis Rheum 49:236–240. https://doi.org/10.1016/j.semarthrit.2019.03.011
Ehrmann Feldman D, Vinet É, Sylvestre MP et al (2017) Postpartum complications in new mothers with juvenile idiopathic arthritis: a population-based cohort study. Rheumatology (Oxford) 56(8):1378–1385. https://doi.org/10.1093/rheumatology/kex168
Oyelese Y, Ananth CV (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53(1):147–156. https://doi.org/10.1097/GRF.0b013e3181cc406d
von Mühlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323–358. https://doi.org/10.1016/s0049-0172(95)80004-2
Mengeloglu Z, Tas T, Kocoglu E et al (2014) Determination of anti-nuclear antibody pattern distribution and clinical relationship. Pak J Med Sci 30:380–383. https://doi.org/10.12669/pjms.302.4276
Ticconi C, Pietropolli A, Borelli B et al (2016) Antinuclear autoantibodies and pregnancy outcome in women with unexplained recurrent miscarriage. Am J Reprod Immunol 76:396–399. https://doi.org/10.1111/aji.12560
Veglia M, D’ippolito S, Marana R et al (2015) Human IgG antinuclear antibodies induce pregnancy loss in mice by increasing immune complex deposition in placental tissue: in vivo study. Am J Reprod Immunol 74:542–552. https://doi.org/10.1111/aji.12429
Ince-Askan H, van den Akker E, de Rijke YB et al (2019) Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort study. RMD Open 5:e000852. https://doi.org/10.1136/rmdopen-2018-000852
de Steenwinkel F, Dolhain R, Hazes J et al (2017) Does prednisone use or disease activity in pregnant women with rheumatoid arthritis influence the body composition of their offspring. Reprod Toxicol 71:118–123. https://doi.org/10.1016/j.reprotox.2017.05.002
Bondt A, Selman MH, Deelder AM et al (2013) Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res 12:4522–4531. https://doi.org/10.1021/pr400589m
Ostensen M, Villiger PM (2007) The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 29:185–191. https://doi.org/10.1007/s00281-007-0072-5
Dolhain RJ (2010) Rheumatoid arthritis and pregnancy; not only for rheumatologists interested in female health issues. Ann Rheum Dis 69:317–318. https://doi.org/10.1136/ard.2009.120741
Jølving LR, Nielsen J, Kesmodel US et al (2018) Children born by women with rheumatoid arthritis and increased susceptibility for chronic diseases: a nationwide cohort study. Arthritis Care Res (Hoboken) 70:1192–1197. https://doi.org/10.1002/acr.23461
Rom AL, Wu CS, Olsen J et al (2016) Parental rheumatoid arthritis and childhood epilepsy: A nationwide cohort study. Neurology 87:2510–2516. https://doi.org/10.1212/WNL.0000000000003424
Littlejohn EA (2020) Pregnancy and rheumatoid arthritis. Best Pract Res Clin Obstet Gynaecol 64:52–58. https://doi.org/10.1016/j.bpobgyn.2019.09.005
de Steenwinkel FDO, Hokken-Koelega ACS, Hazes JMW, Dolhain RJEM (2014) The influence of foetal prednisone exposure on the cortisol levels in the offspring. Clin Endocrinol 80(6):804–810. https://doi.org/10.1111/cen.12388
Funding
This work was supported by China International Medical Foundation (No. Z-2018–40-2101), Beijing Municipal Science and Technology Project (No. Z191100006619112), and Beijing Natural Science Foundation (No.7192211).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Luo, L., Li, X., Yan, R. et al. Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring. Clin Rheumatol 41, 3135–3141 (2022). https://doi.org/10.1007/s10067-022-06233-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06233-9